Skip to search.
 TSX Up 0.57% TSX Ventures Up 0.61%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.19 Up 0.00(1.09%) Jul 30, 4:00PM EDT
Add to Portfolio
Prev Close:0.18
Open:0.18
Bid:0.17 x 300
Ask:0.22 x 900
1y Target Est:1.45
Beta:-0.33
Next Earnings Date:N/A
Day's Range:0.18 - 0.20
52wk Range:0.17 - 0.40
Volume:695,612
Avg Vol (3m):1,321,400
Market Cap:44.87M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBUp 1.09%44.87M
GILDUp 1.89%173.27B
MRKDown 0.03%165.33B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):271.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback